Capricor Therapeutics (CAPR)
(Delayed Data from NSDQ)
$18.86 USD
+0.37 (2.00%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $18.84 -0.02 (-0.11%) 7:14 PM ET
2-Buy of 5 2
F Value F Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/12/24 |
---|---|
Current Quarter | -0.34 |
EPS Last Quarter | -0.35 |
Last EPS Surprise | -9.38% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.13 |
Next Year | -0.30 |
EPS (TTM) | -0.93 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 4.31M | 5.96M | 19.15M | 29.30M |
# of Estimates | 2 | 2 | 2 | 2 |
High Estimate | 5.00M | 6.00M | 19.90M | 35.00M |
Low Estimate | 3.61M | 5.91M | 18.40M | 23.60M |
Year ago Sales | 6.19M | 12.09M | 25.18M | 19.15M |
Year over Year Growth Est. | -30.45% | -50.74% | -23.94% | 53.00% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.34 | -0.33 | -1.13 | -0.30 |
# of Estimates | 2 | 2 | 4 | 3 |
Most Recent Consensus | NA | NA | -1.28 | -1.33 |
High Estimate | -0.31 | -0.29 | -0.60 | 1.53 |
Low Estimate | -0.36 | -0.36 | -1.38 | -1.33 |
Year ago EPS | -0.25 | -0.02 | -0.83 | -1.13 |
Year over Year Growth Est. | -36.00% | -1,550.00% | -36.14% | 73.75% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 1 |
Up Last 30 Days | 0 | 1 | 3 | 3 |
Up Last 60 Days | 0 | 1 | 3 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.34 | -0.33 | -1.13 | -0.30 |
7 Days Ago | -0.34 | -0.33 | -1.13 | -0.31 |
30 Days Ago | -0.34 | -0.33 | -1.24 | -0.43 |
60 Days Ago | -0.34 | -0.33 | -1.24 | -0.43 |
90 Days Ago | -0.33 | 0.01 | -1.04 | -0.38 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.34 | -0.29 | -1.05 | -0.30 |
Zacks Consensus Estimate | -0.34 | -0.33 | -1.13 | -0.30 |
Earnings ESP | 0.00% | 10.77% | 7.37% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.35 | -0.31 | -0.02 | -0.25 | NA |
Estimate | -0.32 | -0.11 | -0.23 | -0.27 | NA |
Difference | -0.03 | -0.20 | 0.21 | 0.02 | 0.00 |
Surprise | -9.38% | -181.82% | 91.30% | 7.41% | -23.12% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more